Yubo International Biotech annual gross margin
2021
2022
2023
2024
2025
Yubo International Biotech Gross Margin Growth & History (YBGJ)
Yubo International Biotech's gross margin was 66.10% for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 66.10% | −10.21 pp |
| 2024 | 2024-12-31 | 76.31% | +6.99 pp |
| 2023 | 2023-12-31 | 69.32% | +18.83 pp |
| 2022 | 2022-12-31 | 50.49% | −15.46 pp |
| 2021 | 2021-12-31 | 65.95% | — |
Yubo International Biotech quarterly gross margin
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q4.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | 66.10% | +4.21 pp |
| Q1 2024 | 2024-03-31 | 76.29% | +39.45 pp |
| Q4 2023 | 2023-12-31 | 91.21% | +47.71 pp |
| Q3 2023 | 2023-09-30 | 80.30% | +14.45 pp |
| Q2 2023 | 2023-06-30 | 61.89% | −11.52 pp |
| Q1 2023 | 2023-03-31 | 36.84% | −17.50 pp |
| Q4 2022 | 2022-12-31 | 43.50% | −30.96 pp |
| Q3 2022 | 2022-09-30 | 65.84% | — |
| Q2 2022 | 2022-06-30 | 73.41% | — |
| Q1 2022 | 2022-03-31 | 54.34% | — |
| Q3 2021 · Sep 30 | 2021-09-30 | 74.46% | — |
Yubo International Biotech gross margin trends
Across the available reported history, Yubo International Biotech's gross margin decreased from 76.31% to 66.10%, a change of −10.21 percentage points. The latest reported quarter, Q4 2025, shows 66.10%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech filings at SEC.gov ↗